Ophthalmologica
Research Article
Intraoperative Optical Coherence Tomography-Guided Membrane Peeling for Surgery of Macular Pucker: Advantages and LimitationsLeisser C. · Hirnschall N. · Palkovits S. · Doeller B. · Kefer K. · Findl O.Vienna Institute for Research in Ocular Surgery (VIROS), a Karl Landsteiner Institute, Hanusch Hospital, Vienna, Austria
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: March 02, 2018
Accepted: August 27, 2018
Published online: November 09, 2018
Issue release date: April 2019
Number of Print Pages: 7
Number of Figures: 4
Number of Tables: 0
ISSN: 0030-3755 (Print)
eISSN: 1423-0267 (Online)
For additional information: https://www.karger.com/OPH
Abstract
Purpose: Epiretinal membranes (ERMs) are a disorder leading to progressive vision loss and metamorphopsia. The gold standard in therapy is vitrectomy with membrane peeling. The aim of this study was to assess whether the use of intraoperative optical coherence tomography (iOCT), which allows tomographic visualization of the membrane during peeling, enables peeling without staining. Methods: This prospective study included 30 eyes of 30 patients with idiopathic ERMs scheduled for surgery. Pars plana vitrectomy with iOCT was performed in all cases, whereas staining of ERMs was only performed if needed. Internal limiting membrane (ILM) peeling was performed in case of wrinkled retinal surface after peeling of ERMs. Results: In 63% (n = 19) eyes the ERM could be peeled successfully without use of staining. Nevertheless, in 89% (n = 17) of patients having had ERM peeling without dye, staining of the ILM was performed afterwards for peeling the ILM. Best corrected visual acuity improved in 80% (n = 24) and remained unchanged in 7% (n = 2) 3 months after surgery. There were no significant differences in postoperative results between patients with and without staining for ERM peeling. Conclusions: Use of iOCT helps to complete ERM peeling in a majority of cases without use of a chromovitrectomy dye, but as iOCT fails to visualize the ILM, chromovitrectomy still facilitates macular surgery in a majority of cases.
© 2018 S. Karger AG, Basel
Related Articles:
References
- Zhao F, Gandorfer A, Haritoglou C, Scheler R, Schaumberger MM, Kampik A, et al. Epiretinal cell proliferation in macular pucker and vitreomacular traction syndrome: analysis of flat-mounted internal limiting membrane specimens. Retina. 2013 Jan;33(1):77–88.
- Kohno RI, Hata Y, Kawahara S, Kita T, Arita R, Mochizuki Y, et al. Possible contribution of hyalocytes to idiopathic epiretinal membrane formation and its contraction. Br J Ophthalmol. 2009 Aug;93(8):1020–6.
- Mitamura Y, Hirano K, Baba T, Yamamoto S. Correlation of visual recovery with presence of photoreceptor inner/outer segment junction in optical coherence images after epiretinal membrane surgery. Br J Ophthalmol. 2009 Feb;93(2):171–5.
- Oster SF, Mojana F, Brar M, Yuson RM, Cheng L, Freeman WR. Disruption of the photoreceptor inner segment/outer segment layer on spectral domain-optical coherence tomography is a predictor of poor visual acuity in patients with epiretinal membranes. Retina. 2010 May;30(5):713–8.
- Shimozono M, Oishi A, Hata M, Matsuki T, Ito S, Ishida K, et al. The significance of cone outer segment tips as a prognostic factor in epiretinal membrane surgery. Am J Ophthalmol. 2012 Apr;153(4):698–704.
- Machemer R. [The surgical removal of epiretinal macular membranes (macular puckers) (author’s transl)]. Klin Monbl Augenheilkd. 1978 Jul;173(1):36–42.
- Kadonosono K, Itoh N, Uchio E, Nakamura S, Ohno S. Staining of internal limiting membrane in macular hole surgery. Arch Ophthalmol. 2000 Aug;118(8):1116–8.
- Gandorfer A, Haritoglou C, Gass CA, Ulbig MW, Kampik A. Indocyanine green-assisted peeling of the internal limiting membrane may cause retinal damage. Am J Ophthalmol. 2001 Sep;132(3):431–3.
- Haritoglou C, Gandorfer A, Gass CA, Schaumberger M, Ulbig MW, Kampik A. Indocyanine green-assisted peeling of the internal limiting membrane in macular hole surgery affects visual outcome: a clinicopathologic correlation. Am J Ophthalmol. 2002 Dec;134(6):836–41.
- Haritoglou C, Gandorfer A, Gass CA, Schaumberger M, Ulbig MW, Kampik A. The effect of indocyanine-green on functional outcome of macular pucker surgery. Am J Ophthalmol. 2003 Mar;135(3):328–37.
- Uemura A, Kanda S, Sakamoto Y, Kita H. Visual field defects after uneventful vitrectomy for epiretinal membrane with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol. 2003 Aug;136(2):252–7.
- Ho JD, Chen HC, Chen SN, Tsai RJ. Reduction of indocyanine green-associated photosensitizing toxicity in retinal pigment epithelium by sodium elimination. Arch Ophthalmol. 2004 Jun;122(6):871–8.
- Cheng SN, Yang TC, Ho JD, Hwang JF, Cheng CK. Ocular toxicity of intravitreal indocyanine green. J Ocul Pharmacol Ther. 2005 Feb;21(1):85–93.
- Yamashita T, Uemura A, Kita H, Nakao K, Sakamoto T. Long-term outcomes of visual field defects after indocyanine green-assisted macular hole surgery. Retina. 2008 Oct;28(9):1228–33.
- von Jagow B, Höing A, Gandorfer A, Rudolph G, Kohnen T, Kampik A, et al. Functional outcome of indocyanine green-assisted macular surgery: 7-year follow-up. Retina. 2009 Oct;29(9):1249–56.
- Kernt M, Hirneiss C, Wolf A, Liegl R, Rueping J, Neubauer A, et al. Indocyanine green increases light-induced oxidative stress, senescence, and matrix metalloproteinases 1 and 3 in human RPE cells. Acta Ophthalmol. 2012 Sep;90(6):571–9.
- Veckeneer M, van Overdam K, Monzer J, Kobuch K, van Marle W, Spekreijse H, et al. Ocular toxicity study of trypan blue injected into the vitreous cavity of rabbit eyes. Graefes Arch Clin Exp Ophthalmol. 2001 Sep;239(9):698–704.
- Perrier M, Sébag M. Epiretinal membrane surgery assisted by trypan blue. Am J Ophthalmol. 2003 Jun;135(6):909–11.
- Stalmans P, Van Aken EH, Melles G, Veckeneer M, Feron EJ, Stalmans I. Trypan blue not toxic for retinal pigment epithelium in vitro. Am J Ophthalmol. 2003 Feb;135(2):234–6.
- Teba FA, Mohr A, Eckardt C, Wong D, Kusaka S, Joondeph BC, et al. Trypan blue staining in vitreoretinal surgery. Ophthalmology. 2003 Dec;110(12):2409–12.
- Haritoglou C, Eibl K, Schaumberger M, Mueller AJ, Priglinger S, Alge C, et al. Functional outcome after trypan blue-assisted vitrectomy for macular pucker: a prospective, randomized, comparative trial. Am J Ophthalmol. 2004 Jul;138(1):1–5.
- Tao YK, Ehlers JP, Toth CA, Izatt JA. Intraoperative spectral domain optical coherence tomography for vitreoretinal surgery. Opt Lett. 2010 Oct;35(20):3315–7.
- Binder S, Falkner-Radler CI, Hauger C, Matz H, Glittenberg C. Feasibility of intrasurgical spectral-domain optical coherence tomography. Retina. 2011 Jul–Aug;31(7):1332–6.
- Ehlers JP, Tao YK, Farsiu S, Maldonado R, Izatt JA, Toth CA. Integration of a spectral domain optical coherence tomography system into a surgical microscope for intraoperative imaging. Invest Ophthalmol Vis Sci. 2011 May;52(6):3153–9.
- Hahn P, Migacz J, O’Connell R, Izatt JA, Toth CA. Unprocessed real-time imaging of vitreoretinal surgical maneuvers using a microscope-integrated spectral-domain optical coherence tomography system. Graefes Arch Clin Exp Ophthalmol. 2013 Jan;251(1):213–20.
- Hahn P, Migacz J, O’Donnell R, Day S, Lee A, Lin P, et al. Preclinical evaluation and intraoperative human retinal imaging with a high-resolution microscope-integrated spectral domain optical coherence tomography device. Retina. 2013 Jul–Aug;33(7):1328–37.
-
Ehlers JP, Kaiser PK, Srivastava SK: Intraoperative optical coherence tomography using the RESCAN 700: preliminary results from the DISCOVER study. Br J Ophthalmol. 2014 Oct;98(10):1329–32.
- Ehlers JP, Srivastava SK, Feiler D, Noonan AI, Rollins AM, Tao YK. Integrative advances for OCT-guided ophthalmic surgery and intraoperative OCT: microscope integration, surgical instrumentation, and heads-up display surgeon feedback. PLoS One. 2014 Aug;9(8):e105224.
- Falkner-Radler CI, Glittenberg C, Gabriel M, Binder S. Intrasurgical microscope-integrated spectral domain optical coherence tomography-assisted membrane peeling. Retina. 2015 Oct;35(10):2100–6.
- Pfau M, Michels S, Binder S, Becker MD. Clinical Experience With the First Commercially Available Intraoperative Optical Coherence Tomography System. Ophthalmic Surg Lasers Imaging Retina. 2015 Nov–Dec;46(10):1001–8.
- Leisser C, Hackl C, Hirnschall N, Luft N, Döller B, Draschl P, et al. Visualizing Macular Structures During Membrane Peeling Surgery With an Intraoperative Spectral-Domain Optical Coherence Tomography Device. Ophthalmic Surg Lasers Imaging Retina. 2016 Apr;47(4):328–32.
-
Ehlers JP, Modi YS, Pecen PE, Goshe J, Dupps WJ, Rachitskaya A, et al. The DISCOVER Study 3-Year Results: Feasibility and Usefulness of Microscope-Integrated Intraoperative OCT during Ophthalmic Surgery. Ophthalmology. 2018 Jul;125(7):1014–27.
- Ehlers JP, Khan M, Petkovsek D, Stiegel L, Kaiser PK, Singh RP, et al. Outcomes of Intraoperative OCT-Assisted Epiretinal Membrane Surgery from the PIONEER Study. Ophthalmol Retina. 2018 Apr;2(4):263–7.
- Liu H, Zuo S, Ding C, Dai X, Zhu X. Comparison of the Effectiveness of Pars Plana Vitrectomy with and without Internal Limiting Membrane Peeling for Idiopathic Retinal Membrane Removal: A Meta-Analysis. J Ophthalmol. 2015;2015:974568.
- Chang WC, Lin C, Lee CH, Sung TL, Tung TH, Liu JH. Vitrectomy with or without internal limiting membrane peeling for idiopathic epiretinal membrane: A meta-analysis. PLoS One. 2017 Jun;12(6):e0179105.
- Ripandelli G, Scarinci F, Piaggi P, Guidi G, Pileri M, Cupo G, et al. Macular pucker: to peel or not to peel the internal limiting membrane? A microperimetric response. Retina. 2015 Mar;35(3):498–507.
- Hida T, Chandler D, Arena JE, Machemer R. Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations. Am J Ophthalmol. 1986 Feb;101(2):190–5.
- Yeung CK, Chan KP, Chiang SW, Pang CP, Lam DS. The toxic and stress responses of cultured human retinal pigment epithelium (ARPE19) and human glial cells (SVG) in the presence of triamcinolone. Invest Ophthalmol Vis Sci. 2003 Dec;44(12):5293–300.
- Narayanan R, Mungcal JK, Kenney MC, Seigel GM, Kuppermann BD. Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells. Invest Ophthalmol Vis Sci. 2006 Feb;47(2):722–8.
- Szurman P, Kaczmarek R, Spitzer MS, Jaissle GB, Decker P, Grisanti S, et al. Differential toxic effect of dissolved triamcinolone and its crystalline deposits on cultured human retinal pigment epithelium (ARPE19) cells. Exp Eye Res. 2006 Sep;83(3):584–92.
- Szurman P, Sierra A, Kaczmarek R, Jaissle GB, Wallenfels-Thilo B, Grisanti S, et al. Different biocompatibility of crystalline triamcinolone deposits on retinal cells in vitro and in vivo. Exp Eye Res. 2007 Jul;85(1):44–53.
- Almeida FP, De Lucca AC, Scott IU, Jorge R, Messias A. Accidental subretinal brilliant blue G migration during internal limiting membrane peeling surgery. JAMA Ophthalmol. 2015 Jan;133(1):85–8.
- Ando F, Yasui O, Hirose H, Ohba N. Optic nerve atrophy after vitrectomy with indocyanine green-assisted internal limiting membrane peeling in diffuse diabetic macular edema. Adverse effect of ICG-assisted ILM peeling. Graefes Arch Clin Exp Ophthalmol. 2004 Dec;242(12):995–9.
- Leisser C, Hirnschall N, Hackl C, Döller B, Varsits R, Ullrich M, et al. Risk factors for postoperative intraretinal cystoid changes after peeling of idiopathic epiretinal membranes among patients randomized for balanced salt solution and air-tamponade. Acta Ophthalmol. 2018 Feb;96(4):e439–44.
- Frisina R, Pinackatt SJ, Sartore M, Monfardini A, Baldi A, Cesana BM, et al. Cystoid macular edema after pars plana vitrectomy for idiopathic epiretinal membrane. Graefes Arch Clin Exp Ophthalmol. 2015 Jan;253(1):47–56.
Article / Publication Details
Received: March 02, 2018
Accepted: August 27, 2018
Published online: November 09, 2018
Issue release date: April 2019
Number of Print Pages: 7
Number of Figures: 4
Number of Tables: 0
ISSN: 0030-3755 (Print)
eISSN: 1423-0267 (Online)
For additional information: https://www.karger.com/OPH
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission